Scholarlink

<p>Hidradenitis suppurativa (HS) is a&#xa0;chronic inflammatory skin and systemic disease that is associated with considerable discomfort and a&#xa0;significant reduction in quality of life. Despite a&#xa0;recently significantly increased understanding of the disease, the diagnosis is still delayed for many years. Delayed patient access to suitable treatment often leads to disease progression with increased surgical interventions and possible comorbidities. In recent years, there has been an improved understanding of the pathophysiology and, as a&#xa0;result, the authorization of modern therapeutics for HS. The treatment of HS is based on three pillars: surgery, antibiotics and biologics. In addition, risk factors such as smoking and obesity should be reduced. Knowledge of comorbidities and their interdisciplinary treatment is important for the individualized care of patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Operationen bei Hidradenitis suppurativa im Kontext moderner Systemtherapie

  • 期刊论文

  • 发表日期：

    2026年5月8日

查看全文
  • M. Alter

摘要

Hidradenitis suppurativa (HS) is a chronic inflammatory skin and systemic disease that is associated with considerable discomfort and a significant reduction in quality of life. Despite a recently significantly increased understanding of the disease, the diagnosis is still delayed for many years. Delayed patient access to suitable treatment often leads to disease progression with increased surgical interventions and possible comorbidities. In recent years, there has been an improved understanding of the pathophysiology and, as a result, the authorization of modern therapeutics for HS. The treatment of HS is based on three pillars: surgery, antibiotics and biologics. In addition, risk factors such as smoking and obesity should be reduced. Knowledge of comorbidities and their interdisciplinary treatment is important for the individualized care of patients.